Response of Chick Parathyroid Glands to the Vitamin D Metabolites, 1,25-Dihydroxycholecalciferol and 24,25-Dihydroxycholecalciferol
- 1 October 1977
- journal article
- research article
- Published by Elsevier in Journal of Nutrition
- Vol. 107 (10) , 1918-1926
- https://doi.org/10.1093/jn/107.10.1918
Abstract
Under conditions of chronic hypocalcemia, e.g. in vitamin D depletion, the parathyroid glands undergo marked hypertrophy and hyperplasia. Seven days of treatment (100 IU/day; 6.5 nmoles) with cholecalciferol (CC) decreased parathyroid gland weight significantly from vitamin D depleted controls while increasing serum Ca from 6.3 to 8.6 mg/100 ml. 1,25-Dihydroxycholecalciferol (1.3 nmoles/day) also increased serum Ca to 8.6, but had no effect on gland weight. Both CC and 1,25-dihydroxycholecalciferol stimulated the production of intestinal calcium binding protein. This same dose of 1,25-dihydroxycholecalciferol in combination with small amounts of 24R,25-dihydroxycholecalciferol was as effective as CC in reducing parathyroid gland weight, but 24R,25-dihydroxycholecalciferol alone had no effect on gland weight or on calcium binding protein synthesis. When chicks received a two- to four-fold larger dose of 1,25-dihydroxycholecalciferol, parathyroid gland weight was significantly reduced relative to vitamin D depleted controls. A time course of the action of CC indicated that 4 days treatment was sufficient for significant parathyroid gland size reduction. Decreases in gland wet weight caused by CC were paralleled by decreases in dry weight, and loss of DNA and protein. It is concluded that parathyroid gland regression, involving loss of cells, occurs within a few days of treatment with vitamin D metabolites and that gland regression does not obligatorily follow an increase in serum Ca. At low doses, 1,25-dihydroxycholecalciferol requires the presence of 24R,25-dihydroxycholecalciferol to cause gland regression (but not intestinal calcium binding protein production), whereas it is effective alone at higher doses. These results suggest that the dihydroxylated vitamin D metabolites may play a role in modulating parathyroid gland as well as intestinal function.Keywords
This publication has 25 references indexed in Scilit:
- Decrease in serum immunoreactive parathyroid hormone in rats and in parathyroid hormone secretion in vitro by 1,25-dihydroxycholecalciferol.Journal of Clinical Investigation, 1975
- Studies on the mechanism of action of calciferol VII. Localization of 1,25-dihydroxy-vitamin D3 in chick parathyroid glandsBiochemical and Biophysical Research Communications, 1975
- Chick brain calcium-binding protein: Comparison with intestinal vitamin D-induced calcium-binding proteinArchives of Biochemistry and Biophysics, 1974
- Relationship between duodenal calcium-binding protein, parathyroid activity and various parameters of mineral metabolism in the rachitic and vitamin D-treated chickComparative Biochemistry and Physiology Part A: Physiology, 1972
- Isolation and identification of 24,25-dihydroxycholecalciferol, a metabolite of vitamin D3 made in the kidneyBiochemistry, 1972
- Vitamin D Metabolism: The Role of Kidney TissueScience, 1971
- Studies on calciferol metabolism I. Production of vitamin D metabolite 4B from 25-OH-cholecalciferol by kidney homogenatesBiochemical and Biophysical Research Communications, 1971
- Vitamin D: A Cholecalciferol Metabolite Highly Active in Promoting Intestinal Calcium TransportScience, 1971
- Unique Biosynthesis by Kidney of a Biologically Active Vitamin D MetaboliteNature, 1970
- Histological studies on the endocorines of chickens deprived of ultraviolet light. I. ParathyroidsJournal of Anatomy, 1927